Stability first
Shared care is generally considered after titration, when the medicine, dose, benefit and adverse effects are sufficiently stable.
After medication is stabilised, a specialist may ask an NHS GP to take on agreed prescribing and monitoring while specialist review continues.
An ADHD assessment does not guarantee a diagnosis, medication, prescription or shared-care agreement. Please do not email medical details.

ADHD care should be careful enough to consider history, daily function, strengths, other possible explanations and the support needed next.
Shared care is generally considered after titration, when the medicine, dose, benefit and adverse effects are sufficiently stable.
The agreement describes what the specialist, GP and patient each monitor, prescribe, review and communicate.
Shared care does not discharge the person from appropriate specialist review or make the NHS GP solely responsible for specialist decisions.
The clinician brings together the person’s account, reliable supporting information, clinical expertise and recognised diagnostic and treatment standards.
The aim is an accurate, useful formulation—not a predetermined outcome.
You may wish to ask your NHS practice about its approach, while recognising that a final decision needs clinical details later.
The specialist documents diagnosis, treatment, response, monitoring and the actions requested from primary care.
The NHS GP considers competence, local arrangements, information, workload and patient safety before accepting or declining.
Dose changes, adverse effects, missed reviews or clinical instability usually return management to the specialist.
Good preparation reduces delay, protects confidentiality and makes the clinical discussion more useful.
Each stage should explain what is needed, who is responsible and what remains subject to clinical review.
Complete specialist titration and required monitoring.
The specialist sends a complete written shared-care proposal.
The NHS GP accepts, asks questions or declines according to safe local practice.
Follow the agreed prescribing, monitoring and specialist-review responsibilities.
Clear expectations matter before assessment, treatment or transfer of care.
No. Shared care requires agreement. Your NHS GP makes an independent decision and may decline.
Usually after specialist initiation and dose stabilisation, with diagnosis, response, monitoring and responsibilities documented.
Yes, where the agreement requires ongoing specialist oversight. The frequency and cost should be clear before shared care is requested.
The specialist should explain the private prescribing and review route or other appropriate options. Do not stop or change medicine without clinical advice.
A material treatment change normally needs specialist review and may temporarily return prescribing responsibility to the specialist, depending on the agreement.
Email your name, contact details and whether the enquiry concerns an adult or a child or young person. Please do not include symptoms, reports, medicines or other medical information in ordinary email; the team will explain the secure clinical route.
Eligibility, clinician, process, current fees and continuing-care scope are confirmed before payment.